HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay A Tischfield Selected Research

Adenine Phosphoribosyltransferase

9/2005Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.
8/2003Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease.
12/2002Gender- and age-dependent changes in kidney androgen protein mRNA expression in a knockout mouse model for nephrolithiasis.
1/2002Induction of alpha-catenin, integrin alpha3, integrin beta6, and PDGF-B by 2,8-dihydroxyadenine crystals in cultured kidney epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jay A Tischfield Research Topics

Disease

14Alcoholism (Alcohol Abuse)
12/2020 - 12/2005
6Neoplasms (Cancer)
12/2014 - 03/2002
5Cystinuria
02/2019 - 03/2010
5Nephrolithiasis
01/2019 - 01/2002
5Tourette Syndrome (Tourette's Syndrome)
07/2015 - 11/2008
4Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
11/2021 - 08/2013
4Cocaine-Related Disorders (Cocaine Addiction)
05/2014 - 06/2008
4Carcinogenesis
12/2012 - 03/2007
3Autism Spectrum Disorder
11/2021 - 08/2013
3Inflammation (Inflammations)
10/2016 - 09/2005
3Genomic Instability
03/2013 - 03/2007
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2021 - 04/2018
2Neuroinflammatory Diseases
01/2019 - 10/2016
2Tobacco Use Disorder (Nicotine Dependence)
05/2014 - 09/2008
2Kidney Calculi (Kidney Stone)
09/2005 - 08/2003
1Opioid-Related Disorders (Opiate Addiction)
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
02/2019
1Chronic Renal Insufficiency
01/2019
1Neurodevelopmental Disorders
01/2018
1Nervous System Diseases (Neurological Disorders)
10/2016
1Mental Disorders (Mental Disorder)
02/2015
1Prostatic Neoplasms (Prostate Cancer)
11/2014
1Urolithiasis
11/2014
1Rheumatoid Arthritis
01/2014
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2013
1Disease Susceptibility (Diathesis)
01/2013
1Lymphoma (Lymphomas)
12/2012
1Melanoma (Melanoma, Malignant)
12/2012
1Breast Neoplasms (Breast Cancer)
12/2012
1Bloom Syndrome
05/2010
1Urinary Bladder Calculi (Bladder Calculi)
03/2010
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2008
1Polyploidy
03/2007
1Substance-Related Disorders (Drug Abuse)
12/2005

Drug/Important Bio-Agent (IBA)

5Cystine (L-Cystine)IBA
02/2019 - 03/2010
52,8-dihydroxyadenineIBA
04/2010 - 01/2002
4Ethanol (Ethyl Alcohol)IBA
01/2019 - 04/2008
4DNA (Deoxyribonucleic Acid)IBA
02/2015 - 12/2005
4Adenine phosphoribosyltransferase deficiencyIBA
04/2010 - 01/2002
4Adenine PhosphoribosyltransferaseIBA
09/2005 - 01/2002
3Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2011
3Proteins (Proteins, Gene)FDA Link
10/2016 - 12/2002
2Neurotransmitter Agents (Neurotransmitter)IBA
11/2021 - 04/2018
2Amino AcidsFDA Link
01/2019 - 09/2008
2Dopamine (Intropin)FDA LinkGeneric
04/2018 - 07/2012
2NicotineFDA Link
01/2018 - 05/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2014 - 07/2012
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2014 - 09/2008
2Adenosine Triphosphate (ATP)IBA
05/2010 - 03/2010
2Messenger RNA (mRNA)IBA
12/2002 - 01/2002
13' Untranslated Regions (3' UTR)IBA
12/2020
1Sulfhydryl Compounds (Thiols)IBA
02/2019
1Interleukin-2 (IL2)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1CreatinineIBA
01/2019
1Interleukin-8 (Interleukin 8)IBA
01/2019
1Interleukin-18 (Interleukin 18)IBA
01/2019
1Glutathione (Reduced Glutathione)IBA
01/2019
1Interleukin-4 (Interleukin 4)IBA
01/2019
1Serotonin (5 Hydroxytryptamine)IBA
04/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1Potassium Channels (Potassium Channel)IBA
01/2017
1GTP-Binding Proteins (G-Protein)IBA
01/2017
1InflammasomesIBA
10/2016
1Nerve Growth Factors (Neurotrophins)IBA
07/2015
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
07/2015
1Biocompatible Materials (Biomaterials)IBA
02/2015
1RNA (Ribonucleic Acid)IBA
02/2015
1EstersIBA
11/2014
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
10/2014
1Estrogens (Estrogen)FDA Link
01/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
11/2013
1von Willebrand FactorIBA
11/2013
1NucleotidesIBA
08/2013
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
08/2013
1Cadherins (E-Cadherin)IBA
08/2013
1Sirtuin 2IBA
03/2013
1Genetic Markers (Genetic Marker)IBA
01/2013
1ChemokinesIBA
12/2012
1LigandsIBA
12/2012
1ResveratrolIBA
01/2012
1Biological ProductsIBA
10/2011
1Epidermal Growth Factor (EGF)IBA
06/2010
1Carboxy-LyasesIBA
05/2010
1Histidine (L-Histidine)FDA Link
05/2010
1DNA HelicasesIBA
05/2010
1Cruciform DNA (Holliday Junctions)IBA
05/2010
1Illicit Drugs (Recreational Drugs)IBA
05/2010
1Carbachol (Carbastat)FDA Link
03/2010
1Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
12/2008
1Neuropeptide YIBA
12/2008
1Cholinergic ReceptorsIBA
09/2008
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
06/2008
1Tachykinin Receptors (Tachykinin Receptor)IBA
06/2008
1NF-kappa B (NF-kB)IBA
04/2008
1Transcription Factors (Transcription Factor)IBA
04/2008
1MutagensIBA
03/2007
1N-nitrosoiminodiacetic acidIBA
12/2005

Therapy/Procedure

5Therapeutics
01/2020 - 03/2002
1Prostatectomy (Retropubic Prostatectomy)
11/2014